Compare Neurocrine Biosciences Inc (NBIX) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Remitly Global Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Remitly Global Inc trades at $23.93 (market cap $5.02B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.5× Remitly Global Inc's market cap. Which is the better fit depends on your goals.
| NBIX | RELY | |
|---|---|---|
Market Cap | $17.40B | $5.02B |
Sector | Health | Technology |
52-Week High | $180.55 | $25.23 |
52-Week Low | $123.10 | $12.20 |
Enterprise Value | $16.49B | $4.41B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
